Revenue-based financing vs asset-based lending, and where license proceeds fit

Revenue-based financing suits companies with steady recurring revenue and few hard assets: repayments flex with sales, but the total owed is fixed. Asset-based lending suits companies with receivables and inventory: usually cheaper, with borrowing-base reporting and covenants. Data license proceeds are neither: a one-time payment with nothing to repay, but uncertain timing.

The short verdict for a CFO

Pick revenue-based financing (RBF) when the company has predictable recurring revenue, few hard assets to borrow against and a use of funds that pays back from sales quickly. Pick asset-based lending (ABL) when the balance sheet carries real receivables and inventory and the finance team can keep up with borrowing-base reporting; it is usually the cheaper of the two. If the business cannot carry any new obligation, neither is the answer.

Data license proceeds sit outside that choice. When a company licenses its operational records to AI developers, it receives a one-time payment, keeps ownership of the data and owes nothing back. The trade-off is certainty: the amount and timing are unknown until a buyer selects the data and the company signs, so proceeds can sit alongside a facility but should never be modeled as committed capital.

RBF, ABL and license proceeds side by side

FactorRevenue-based financingAsset-based lendingData license proceeds
What it isAn advance repaid as a share of monthly revenue until a fixed total is reachedA revolving line, sometimes with a term piece, secured by receivables, inventory and other assetsA one-time payment for licensing existing operational records for an agreed use and term
What gets underwrittenRevenue history, retention, gross margin, bank and billing dataCollateral quality: aging, concentration, inventory turns, field exam findingsRecords, rights and an authorized sponsor, checked before any buyer sees the opportunity
How cost shows upA fixed repayment multiple; the effective annual rate climbs when revenue grows and repayment speeds upInterest on the drawn balance plus unused-line, field exam and legal feesNo interest; SourceX's fee sits inside one all-in price with no separate charges
RepaymentFlexes with revenue each monthCollections often run through a lockbox that pays down the lineNothing to repay
Covenants and reportingUsually light: revenue reporting and limits on other borrowingBorrowing base certificates, periodic field exams, often a springing fixed-charge coverage testNo financial covenants; the license terms govern use of the data, exclusivity and delivery
DilutionNone, though some providers ask for warrantsNoneNone
Claim on assetsOften a general lienFirst lien on the borrowing-base assetsNo lien; the buyer receives a license, not title
Time to cashFast once bank and billing connections are reviewedSlower: collateral audit and loan documents come firstLongest and least predictable: qualification, inventory, pricing and buyer review first, then payment typically within about 60 days of invoicing once a buyer selects the data
Certainty of amountKnown at signingAvailability known, but it moves with the borrowing baseUnknown until price and terms are agreed and signed
Typical fitSubscription and software businesses with low hard assetsDistributors, manufacturers and staffing firms with large receivablesUS companies with 50+ full-time employees at peak (contractors excluded), several years of records and the rights to license them

When revenue-based financing wins

RBF wins when speed and flexibility matter more than price. Providers underwrite the revenue line rather than the balance sheet, so a subscription business with modest receivables and no inventory can still raise.

It tends to fit when:

  • Revenue is recurring, retention is steady and gross margin can absorb a revenue share.
  • The use of funds has a short, measurable payback, such as a sales hiring cohort or a marketing program.
  • There is little collateral a bank would lend against.
  • The owners want to avoid dilution and a long loan document.

The trap is the fixed multiple. Because the total repayment is set at signing, faster growth means faster repayment and a higher effective annual cost. Model the effective rate in a slow case and a fast case before you sign, and read the default triggers as carefully as the pricing.

When asset-based lending wins

ABL wins on cost when the collateral is real and the finance team is disciplined. The lender advances against eligible receivables and inventory, so the line grows with the business.

It tends to fit when:

  • Receivables come from creditworthy customers without heavy concentration in one account.
  • Inventory is the kind a lender can count, value and sell.
  • The controller can produce borrowing base certificates on schedule and get through a field exam without surprises.
  • Working capital swings with seasons or large orders.

The trap is that availability shrinks when receivables shrink, which is usually when cash is tightest. Track ineligibles every month: aged invoices, cross-aging, concentration limits and contra accounts all reduce what you can draw.

Where license proceeds fit, and where they do not

License proceeds are not financing. They monetize an asset most companies already own but never carry on the balance sheet: years of email, chat, CRM, finance, support, engineering and operations records. The page on hidden assets that are not on the balance sheet explains why those records rarely show up in a valuation.

They make sense as a complement when:

  • The company wants cash without adding debt service, a lien or new shareholders.
  • It keeps records across many systems; strong candidates usually run 10-15+ systems, often with 5-10+ years of history.
  • Leadership is open to a license that is typically exclusive for AI training for an agreed term. Weigh that commitment with the analysis of exclusive data license opportunity cost.

They do not fit when:

  • Cash must arrive by a fixed date, such as payroll, a covenant cure or a maturity.
  • The records mainly belong to the company's clients, are mostly consumer personal data or protected health information, or were already deleted.
  • The company never reached 50+ full-time employees at peak (contractors excluded).
  • The same data has already been licensed for AI training.

Illustrative: a fictional 160-person regional distributor needs seasonal working capital and has a clean receivables book. ABL is the right primary tool. In parallel, its CFO screens whether twelve years of order, dispatch and customer support records could support a license. If one closes, the payment reduces reliance on the line; if not, nothing in the financing plan changes.

The 3C rule for sequencing the options

Ask three questions, in this order, before choosing.

  1. Certainty: must the cash arrive by a specific date? If yes, only a committed facility qualifies. License proceeds can be upside, never the plan.
  2. Cost: compare the effective annual cost of RBF and ABL under realistic revenue cases, including fees, field exams and the value of any warrants. License proceeds carry no financing cost, but they do take internal time for the data inventory and exports.
  3. Claims: list what each option takes in return: a revenue share, a lien and covenants, or exclusivity over a dataset's AI-training use for a term. If a lender already holds a blanket lien, ask counsel whether the credit agreement requires lender consent before any data license is signed.

The company fit checker is a quick, non-binding way to test the third path while the financing work continues, and the full baseline is on who qualifies.

Rights diligence replaces collateral diligence

A lender diligences collateral. A data license is diligenced on rights: did the company create the records, and do its contracts, notices and policies allow licensing? Promises the company made about customer data still apply. FTC staff wrote in February 2024 that quietly adopting more permissive data practices, such as using consumers' data for AI training, through a retroactive change to terms of service or a privacy policy could be unfair or deceptive. That post is staff guidance, not a rule, but it is a good reason to check what the company promised before anything is licensed.

Redaction rules are settled with the company first, and records leave its control only under an executed agreement it has authorized. This is general information, not legal, tax or financial advice. Confirm with your own counsel, tax adviser or professional body before acting.

For fractional CFOs who make the introduction

A fractional CFO is often the first person to see both the financing need and the records. If a client fits, you can introduce it through SourceX's partner program; the fractional CFO partner page covers the role in detail.

Partners earn 25% of the eligible platform fees SourceX actually collects from the referred company's licensing deals, capped at $100,000 per referred company. Rewards are payable only after the buyer pays and SourceX receives its fee, and no reward is guaranteed. The reward is a share of SourceX's fee, so it never reduces what the client receives. Check your own professional rules on referral fees and disclosure first.

Next step

Finish the financing decision on its own merits, then screen the records separately. If the client fits, register as a partner and make the introduction, or ask the CEO to apply directly at sourcex.si/apply with your referral link.

Common questions

Is revenue-based financing more expensive than asset-based lending?

Usually, yes. RBF prices risk into a fixed repayment multiple and does not rely on collateral, while an asset-based lender is secured by receivables and inventory it can collect or sell. The gap widens when revenue grows quickly, because faster repayment raises the effective annual cost of RBF. Compare both on an effective annual basis, including fees, field exams and any warrants, rather than on headline terms.

Can a company have an ABL facility and license its data at the same time?

Often it can, but read the credit agreement first. Many facilities include a blanket lien and limits on selling or licensing assets outside the ordinary course of business, so the company's counsel should confirm whether lender consent or notice is needed. A data license transfers no title and creates no new debt, but the lender's documents decide what is permitted.

Does a data license payment count as debt on the balance sheet?

No. A license the company grants is a sales-side contract, not borrowing, so there is no principal to repay and no interest. How and when the payment is recognized depends on the license terms, so the company should confirm the accounting with its auditor before signing and before it shows the proceeds in a forecast or a covenant calculation.

How quickly can license proceeds arrive compared with closing an ABL facility?

More slowly and less predictably. The company is qualified, completes a data inventory and agrees price and terms before buyers review; once a company is deal-ready, buyers typically respond within about two weeks. Payment typically follows within about 60 days of invoicing once a buyer selects the data. An ABL facility, by contrast, has a closing date the CFO can plan around.

What happens to revenue-based financing payments if sales fall?

Payments fall with revenue, which is the main advantage of RBF over a fixed loan schedule. The total amount owed does not change, so a slowdown stretches the repayment period rather than reducing the cost. Read the agreement for minimum payment clauses, default triggers tied to revenue declines and any rights the provider holds over the company's bank accounts.

Free resources

By SourceX Partnerships Team · Published 2026-10-09 · Updated 2026-10-09

Know a US company with valuable proprietary data?

Become a referral partner from anywhere we support, get your link and introduce an owner or authorized decision-maker.

Refer a company →

I own a business

Explore licensing your company's data to AI developers worldwide. Start a short assessment; no uploads needed.

Start an assessment